We are live on ! Find out more
OACC

Oaktree Acquisition Corp III Life Sciences
OACC

49 hedge funds and large institutions have $179M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more funds holding

Funds holding: 48 → 49 (+1)

2% more capital invested

Capital invested by funds: $175M → $179M (+$3.56M)

0.88% more ownership

Funds ownership: 84.32% → 85.19% (+0.88%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
10
Reduced
12
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
+$1.6M
2
ECP
Empyrean Capital Partners
California
+$1.59M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$1.57M
4
DAM
Decagon Asset Management
United Kingdom
+$331K
5
SC
Sculptor Capital
New York
+$323K

Top Sellers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$2.74M
2
PC
Periscope Capital
Ontario, Canada
-$811K
3
MC
Meteora Capital
Florida
-$609K
4
MSU
Mizuho Securities USA
New York
-$476K
5
DCM
Driehaus Capital Management
Illinois
-$453K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tenor Capital Management
New York
$3.17M – – –
UOC
27
UBS O'Connor
Illinois
$3.17M – – –
Millennium Management
28
Millennium Management
New York
$2.9M – – –
COPPSERS
29
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.65M -$266K -25,170 -9%
WA
30
Whitebox Advisors
Minnesota
$2.65M – – –
LPC
31
Lineage Point Capital
Florida
$2.46M +$2.46M +232,642 New
WRBC
32
W.R. Berkley Corp
Connecticut
$2.37M – – –
KPF
33
K2 Principal Fund
Ontario, Canada
$2.07M – – –
MC
34
Meteora Capital
Florida
$2.02M -$609K -57,522 -23%
DAM
35
DLD Asset Management
New York
$1.43M +$98.9K +9,346 +7%
SSA
36
Schonfeld Strategic Advisors
New York
$1.22M -$104K -9,826 -8%
UBS Group
37
UBS Group
Switzerland
$1.06M +$18.6K +1,760 +2%
PMAM
38
Picton Mahoney Asset Management
Ontario, Canada
$794K – – –
JP Morgan Chase
39
JP Morgan Chase
New York
$530K -$264K -24,923 -33%
Citigroup
40
Citigroup
New York
$478K -$62.4K -5,900 -12%
CC
41
Centiva Capital
New York
$429K – – –
RC
42
Rangeley Capital
Connecticut
$424K +$23.3K +2,205 +6%
RAM
43
Readystate Asset Management
Illinois
$266K – – –
MSU
44
Mizuho Securities USA
New York
$260K -$476K -45,000 -64%
CS
45
Clear Street
New York
$222K -$10.6K -1,000 -5%
Geode Capital Management
46
Geode Capital Management
Massachusetts
$162K – – –
KC
47
Kepos Capital
New York
$159K – – –
BI
48
Bulldog Investors
New Jersey
$143K – – –
Morgan Stanley
49
Morgan Stanley
New York
$571 +$561 +53 +5,300%
1
2

OACC Hedge Fund Activity: Q4 2025 in Review

49 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences (OACC) for Q4 2025, worth a combined $179M — up 2% from $175M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new OACC positions and 0 closed out — a net gain of 1 holder — while 10 added to existing stakes and 12 trimmed.

The largest buyer was Radcliffe Capital Management, adding an estimated $1.6M. The largest seller was Toronto Dominion Bank, cutting an estimated $2.74M.

  • 49 institutional investors held Oaktree Acquisition Corp III Life Sciences (OACC) as of Q4 2025, up from 48 in Q3 2025.
  • Funds reported $179M of Oaktree Acquisition Corp III Life Sciences stock for Q4 2025, up 2% quarter-over-quarter.
  • 1 fund opened new Oaktree Acquisition Corp III Life Sciences positions in Q4 2025 and 0 closed out, a net change of +1 holder.
  • The largest Oaktree Acquisition Corp III Life Sciences buyer in Q4 2025 was Radcliffe Capital Management, an estimated $1.6M added.
  • The largest Oaktree Acquisition Corp III Life Sciences seller in Q4 2025 was Toronto Dominion Bank, an estimated $2.74M sold.

Based on aggregated 13F filings for Q4 2025.